Latest debt-to-equity ratio
Generate Biomedicines Debt-to-equity ratio
Direct answer
Generate Biomedicines's debt-to-equity ratio is 13.73%.
The verified market snapshot reports 13.73%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 7, 2026.
Get free Generate Biomedicines email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 13.73%
Explore related company data
View Generate Biomedicines's market capitalizationView Generate Biomedicines's price-to-book ratioView Generate Biomedicines's dividend yieldView Generate Biomedicines's 52-week price rangeView Generate Biomedicines's revenue growthView Generate Biomedicines's profit marginView all Generate Biomedicines key metricsReturn to Generate Biomedicines profile